Oncology Clinical Specialist
Training & provider links
ABPTS OncPT board certification. Growing field with emerging evidence. No comparative outcome studies yet between certified and non-certified oncology PT.
Six dimensions per lens, each with its reasoning.
Oncology rehab is a growing field with positive evidence; OncPT certification-specific outcomes not yet published.
Applicable in oncology rehabilitation and cancer survivorship programs; limited outside these specialty settings.
Oncology rehab billed under standard PT codes; OncPT does not unlock new billing codes.
ABPTS OncPT certification; experience requirements plus exam; moderate to significant investment.
Growing demand as oncology rehab becomes established; limited current employer base but strong trajectory.
Cancer patients value specialized PT who understands treatment side effects.
Oncology rehab is largely insurance/hospital-based; cash-pay survivorship niches exist but are small.
Rare credential supports some premium, but payer mix dampens realized pricing.
Very few PTs hold this; strong differentiation if you build a survivorship/lymphedema-adjacent niche.
Hard to scale through other clinicians without each holding the cert or extensive mentoring.
Limited direct-to-consumer awareness; referrals come through oncologists, not patient search.
ABPTS board cert is expensive, exam-heavy, with substantial clinical-hour prerequisites.
ABPTS board specialty; gold-standard credential for faculty hiring, promotion, and tenure files.
Holders are typically publishing in survivorship, exercise oncology, and lymphedema literatures.
Strengthens medical/oncology content in DPT curricula and supports residency development.
Exercise oncology has a robust and growing RCT base (ACSM roundtable, survivorship guidelines).
Programs increasingly want oncology coverage; preferred when listed but not universally required.
High time/cost burden relative to a generalist faculty hire.
The citation library behind every score.
- 11
- 17%
- 10
- 16%
- 7
- 11%
- 5
- 8%
- 4
- 6%
- 4
- 6%
- 3
- 5%
- 2
- 3%
- 2
- 3%
- 1
- 2%
- 14
- 22%